Skip to content

Research and application of perioperative multidimensional comprehensive lung protection strategies for elderly patients with fragile lung in the context of novel coronavirus pneumonia epidemic

Research and application of perioperative multidimensional comprehensive lung protection strategies for elderly patients with fragile lung in the context of novel coronavirus pneumonia epidemic

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079847
Enrollment
Unknown
Registered
2024-01-15
Start date
2024-01-20
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung injury

Interventions

Trial group:Multimode protection

Sponsors

Shanghai Gongli Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Age = 65 years old; ? ASA level I~II, cardiac function level I~II; ? Emergency surgery with a duration of>2 hours; ? Clear consciousness, no difficulty swallowing medication, and can cooperate with medication treatment; ? Basic disease control is feasible; ? Undiagnosed novel coronavirus pneumonia; ? The patient has signed an informed consent form.

Exclusion criteria

Exclusion criteria: ? The research subjects are suspected/confirmed COVID-19 patients; ? Incomplete clinical data; ? Patients with pulmonary bullae, high intracranial pressure, etc. who cannot undergo positive end expiratory pressure (PEEP) ventilation; ? Patients who have serious complications with other organs and are temporarily unable to undergo surgery; ? Patients with combined coagulation or platelet abnormalities; ? Within 30 days before admission or during the course of the disease, steroid hormone or immunosuppressive therapy was applied; ? Patient Refusal Cooperation, voluntary withdrawal.

Design outcomes

Primary

MeasureTime frame
PPCs;

Secondary

MeasureTime frame
IL-6;IL-10;CC-16;RAGE;SOD;LPO;TNF-a;

Countries

China

Contacts

Public ContactJianrong Guo

Shanghai Gongli Hospital

jianrguo@126.com+86 189 1617 4776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026